Search

Your search keyword '"Kotecha, Tushar"' showing total 314 results

Search Constraints

Start Over You searched for: Author "Kotecha, Tushar" Remove constraint Author: "Kotecha, Tushar"
314 results on '"Kotecha, Tushar"'

Search Results

1. Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patients

2. Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study

3. The Impact of Bariatric Surgery on Coronary Microvascular Function Assessed Using Automated Quantitative Perfusion CMR

4. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

5. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease

6. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention

7. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

8. Cardiovascular magnetic resonance myocardial perfusion mapping for the assessment of coronary artery disease

9. Automated Inline Analysis of Myocardial Perfusion MRI with Deep Learning

10. Automated Detection of Left Ventricle in Arterial Input Function Images for Inline Perfusion Mapping using Deep Learning: A study of 15,000 Patients

11. Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping

13. Abstract 13074: Incremental Value of Abnormal Quantitative Myocardial Perfusion and Myocardial Infarction Using Cardiovascular Magnetic Resonance as Prognostic Markers in Type 2 Diabetes Mellitus

14. Abstract 11740: Redefining Cardiac Involvement in Systemic Immunoglobulin Light Chain Amyloidosis and Treatment Implications

15. Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study

16. Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.

17. Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.

18. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease

22. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

23. Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis

24. Myocardial perfusion in cardiac amyloidosis

26. Cardiovascular Magnetic Resonance (CMR) in Transthyretin Amyloid Cardiomyopathy – a Study of Natural History of Treatment Response

27. Native Myocardial T1 and Right Ventricular Size by CMR Are Independently Prognostic in Systemic Sclerosis-associated Pulmonary Hypertension

29. Right Ventricular Contractile Reserve by Exercise CMR Is Prognostic in Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension (SSc-PAH) and a Low- or Intermediate-risk PAH Profile

30. Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy

32. Albuminuria in cardiac ATTR amyloidosis: prevalence, progression and prognostic importance

33. Deep phenotyping of p.(V142I)‐associated variant ATTR amyloid cardiomyopathy: distinct from wild‐type ATTR amyloidosis?

34. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina

36. Myocardial Edema and Prognosis in Amyloidosis

37. Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping

41. Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance.

45. Kiosk 1R-FB-04 - Cardiovascular Magnetic Resonance (CMR) in Transthyretin Amyloid Cardiomyopathy – a Study of Natural History of Treatment Response

48. COVID-19: Myocardial Injury in Survivors

49. The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence–Based Approach Using Perfusion Mapping

50. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease

Catalog

Books, media, physical & digital resources